Research map: Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting

Back to the article

Papers in this map

  1. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update · Thomas J. Smith · 2015 · 925 citations · Cited by this paper
  2. LIPOSOMAL NANOFORMULATION OF A COPPER-BASED COMPLEX ASSOCIATED WITH PARPI MODULATES ANGIOGENIC PROCESSES IN ENDOTHELIAL CELLS · 2026 · Related
  3. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines · Jean A. Klastersky · 2016 · 775 citations · Cited by this paper
  4. THERANOSTIC APPLICATION OF PSMA IN ADENOID CYSTIC CARCINOMA: ¹⁸F-PSMA PET/CT IMAGING AND ¹⁷⁷LU-PSMA THERAPY — A CASE REPORT · 2026 · Related
  5. Current status of autologous stem cell transplantation for multiple myeloma · Rama Al Hamed · 2019 · 237 citations · Cited by this paper
  6. Hemovigilance in a Brazilian Amazon blood center: A temporal analysis of 5-year consumption patterns · 2026 · Related
  7. A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia · Brian Dulisse · 2013 · 85 citations · Cited by this paper
  8. Socio-demographic and therapeutic profile of people living with thalassemia in Brazil between 2012 and 2022: A cross-sectional study · 2026 · Related
  9. Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review · Sarah E. Mitchell · 2016 · 70 citations · Cited by this paper
  10. EGFR-TARGETING GE11-DERIVED PEPTIDE DIFFERENTIALLY MODULATES TRIPLE-NEGATIVE BREAST CANCER AND GLIOBLASTOMA CELL PROLIFERATION IN VITRO · 2026 · Related
  11. Systematic Review and Meta-analysis of Short- versus Long-Acting Granulocyte Colony-Stimulating Factors for Reduction of Chemotherapy-Induced Febrile Neutropenia · Paul Cornes · 2018 · 64 citations · Cited by this paper
  12. Therapeutic plasma exchange in acute liver failure: Unravelling its efficacy and impact · 2026 · Related
  13. Pegfilgrastim compared with filgrastim after high‐dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients · Massimo Vincenzo Martino · 2006 · 45 citations · Cited by this paper
  14. RACIAL DISPARITIES IN BRAZILIAN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: EXPLORATORY ANALYSIS OF EPIDEMIOLOGICAL PROFILE AND IMMUNE SENESCENCE/EXHAUSTION PROTEINS · 2026 · Related
  15. Outpatient allogeneic hematopoietic stem-cell transplantation: a review · David Gómez‐Almaguer · 2022 · 29 citations · Cited by this paper
  16. CT-DERIVED BODY COMPOSITION AND MACHINE LEARNING FOR PROGNOSTIC IMPROVEMENT IN COLORECTAL CANCER · 2026 · Related
  17. Autologous Stem Cell Transplantation in Patients With Multiple Myeloma: An Activity-based Costing Analysis, Comparing a Total Inpatient Model Versus an Early Discharge Model · Massimo Vincenzo Martino · 2017 · 23 citations · Cited by this paper
  18. Mineral disorders after hematopoietic stem cell transplantation in patients receiving parenteral nutrition · 2026 · Related
  19. Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients · Sherry P Mathew · 2010 · 22 citations · Cited by this paper
  20. False-positive test results: prevalence, time trends, and factors associated with false-positive serological markers in blood donation screening · 2026 · Related
  21. Pegfilgrastim vs. filgrastim for supportive care after autologous stem cell transplantation: can we decide? · Panayiotis D. Ziakas · 2011 · 16 citations · Cited by this paper
  22. A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®) · Gina G. Wong · 2020 · 11 citations · Cited by this paper
  23. High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma · José Antonio Fernández-Gutiérrez · 2022 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)